Ergoteles LLC Poseida Therapeutics, Inc. Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$3.08 - $8.73 $100,408 - $284,598	32,600 New	32,600 $100,000
Q3 2022 Nov 14, 2022	SELL	$2.43 - $4.51 $103,221 - $191,575	-42,478 Reduced 31.16%	93,842 $331,000
Q2 2022 Aug 12, 2022	BUY	$1.87 - $5.0 $254,918 - $681,600	136,320 New	136,320 $352,000
Q3 2021 Nov 15, 2021	SELL	$7.09 - $10.71 $200,647 - $303,093	-28,300 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$7.96 - $10.07 $225,268 - $284,981	28,300 New	28,300 $284,000

38.5M

377K

22.2K

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $810M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.